510 (K) Summary: Submitter Information
510 (K) Summary: Submitter Information
510 (K) Summary: Submitter Information
EB Neuro, S.p.A.
(073 5
Nemus MAY 2 320
510(k) Summary
The following 5 10(k) summary has been prepared pursuant to requirements specified in
2 1 CFR¶807.92(a).
807.92(a)(1)
Submitter Information
Allison Scott
Official Correspondent
The Anson Group
11460 N. Meridian St.
Suite 150
Carmel, IN 46032
807.92(a)(2~)
807.92(a)(3)
Predicate Device(s)
Esaote Biomedica PHASIS K922488
Oxford Instruments PLC Sinergy LT K98 1405
807.92 (a)(4)
Device Description
There are two configurations of NeMus: NeMus System and NeMus PC Peripheral.
The "Nemus system" is a complete system provided with a cart (expressly designed for this
device and equipped with isolation transformer, the base unit support mobile arm, places for
computer, keyboard, footswitch, printer, and dedicated keyboard and so on. The complete system
provided of all the part ordered by the customer is completely wired, assembled and tested in
factory before to ship to the final user. Like the hardware parts, all the needed software is
installed and configured in factory.
The "Nemus PC Peripheral" is a base kit (constituted by the NeMus 1 Amplifier the AC/DC
adapter, cables and GALILEO NT management software) which, by adding a Personal
Computer, becomes a digital electromiograph system. This configuration is developed and
verified in order to allow a Distributor or the User to "build" an acquisition/processing EMG
signal system by using the NeMus 1 acquisition module, the GALILEO NT/MYTOWIN
management software and their own Personal Computer (and peripherals). However the PC must
be compliant with EBNeuro specified minimum requirements. Of course the "system builder"
must follow all the indications detailed in the related User Manual provided withthe-system. In
this kind of system configuration, the "base kit" provided by EBNeuro is a sort of "peripheral" of
a PC system. This configuration allows the Distributor or the User to use its own PC, cart or
other "system" arrangement of its choice.
NeMus systems are diagnostic medical systems able to detect the electric signals produced by the
peripheral nerve system and by skeletal muscles.
The Nemus system is intended to monitor, record and display the bioelectric signal produced by
the muscles, to stimulate peripheral nerves, and to monitor, record and display the electrical
activity produced by nerves to aid the clinician in the diagnosis and prognosis of neuromuscular
diseases (EMG). The device may use electrical stimulus, visual stimulus or sound stimulus for
use in evoked response measurements (EP).
807.92(a)(5)
Intended Use(s)
NEMUS systems are diagnostic medical systems able to detect the electric signals produced by
the peripheral nerve system and by skeletal muscles.
The NEMUS system is intended to monitor, record and display the bioelectric signal produced by
the muscles, to stimulate peripheral nerves, and to monitor, record and display the electrical
activity produced by nerves to aid the clinician in the diagnosis and prognosis of neuromuscular
diseases (EMG). The device may use electrical stimulus or sound stimulus for use in evoked
response measurements (EP).
510(k) Summary
EB Neuro, S.p.A.
Nemus
807.92(a)(6)
Technological Characteristics
Substantial Equivalence Comparison Table
Regulatory
Labeling
Design - General
Customization of Via storage / retrieval of Via storage / retrieval of Via storage / retrieval
clinical protocols user-defined settings user-defined settings of user-defined settings
Application Via software update Via software update Via software update
flexibility /
expandability
System Power From mains (110-240 From mains (110-240 From mains (110-240
Supply VAC) trough isolation VAC) VAC)
transformer
Amplifier Power 15 VDC from medical Internal power supply Internal power supply
Supply approved AC/DC
converter
Size (H/W/D) mm 238/457/413 500/209/321
Nemus System: (cart: 720/640/780)
1250/750/850 (complete
system, with cart, monitor,
arm)
Design - Acquisition
Low pass filter 20 Hz- 16 kHz (15 10 Hz- 20 KHz (11 50 Hz- 16 kHz (10
step) step) step)
High pass filter 0.01 - 500 Hz (11 step) 0.01- 500 Hz (13 step) DC, 30 - 2000 Hz
Trigger mode Free, Auto, Internal, Recurrent, manual, self, Auto, Internal, External
External external
Signal delay 0-5 div 0-5 div 0 -9 div
(pre/post)
Ohmmeter 0-100 kOhm (auto full 0-100 kOhm (auto full 0 - 32 kOhm
scale) scale)
510(k) Summary
EB Neuro, S.p.A.
Nemus
Design - Stimulators
Somatosensory
(electrical) Stimulator Type: constant current Type: constant Type: constant
current/voltage current/voltage
N. output: 1 N. output: 1 N. output: 1
Max output: 100 mA Max output:O00 mA Max output: 100 mA
Pulse width: 0.05- Pulse width: 0.01 - 1 ms Pulse width: 0.05-1 ms
lms Mode: single, recurrent, Mode: single, double,
Mode: single, train paired, trains train
Audio Stilmulator
Output mode: click, Output mode: click, pip, Output mode: click,
tone tone pip, tone
Sound pressure: 0-132 Sound pressure:20-132 Sound pressure: 0-122
dB SPL dB SPL dB SPL
Phase: condens., raref, Phase: condens., raref, Phase: condens., raref.,
alternate alternate alternate
Signal frequency: 125- Signal frequency: 125- Signal frequency: 125-
8000 Hz 8000 Hz 8000 Hz
Plateau time: 1-200 ms Plateau time: 0-200 ins Plateau time: 1-999 ms
Rise/fall time: 1-100 Rise/fall time: 0-200 ms Rise/fall time: 1-255 ms
ms Mask level: 0-90 dB Mask level: -40 - +10
Mask level: -40 - +10 dB (relative)
dB (relative) Click width: 50-500 Is Click width: 0. 05-1Ims
Click width: 1-100 Is Stimulus presen. Left, Stimulus presen. Left,
Stimulus presen. Left, right, binaural right, binaural
right, binaural Headset: TDH 50P Headset: TDH 39
Headset: TDH 39
Basic EP application
modules
Re: K073415
Trade/Device Name: Nemus System and Nemus PC Peripheral
Regulation Number: 21 CFR 890.1375
Regulation Name: Diagnostic Electromyograph
Regulatory Class: Class II
Product Code: IKN, GWF, GWJ, JXE
Dated: May 9, 2008
Received: May 12, 2008
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced
above and have determined the device is substantially equivalent (for the indications for use stated in
the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to
May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been
reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that
do not require approval of a premarket approval application (PMA). You may, therefore, market the
device, subject to the general controls provisions of the Act. The general controls provisions of the Act
include requirements for annual registration, listing of devices, good manufacturing practice, labeling,
and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may
be subject to such additional controls. Existing major regulations affecting your device can be found in
the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further
announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that
FDA has made a determination that your device complies with other requirements of the Act or any
Federal statutes and regulations administered by other Federal agencies. You must comply with all the
Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling
(21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS)
regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions
(Sections 531-542 of the Act); 21 CFR 1000-1050.
Page 2 - Ms. Allison Scott
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device to
proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance
at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket
notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact
CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240)
276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting
(MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other
general information on your responsibilities under the Act from the Division of Small Manufacturers,
International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the
Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark N. Melkerson
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure
Indications for Use
510(k) Number (if known):
NEMUS systems are diagnostic medical systems able to detect the electric signals produced by
the peripheral nerve system and by skeletal muscles.
The NEMUS system is intended to monitor, record and display the bioelectric signal produced
by the muscles, to stimulate peripheral nerves, and to monitor, record and display the
electrical activity produced by nerves to aid the clinician in the diagnosis and prognosis of
neuromuscular diseases (EMG). The device may use electrical stimulus or sound stimulus for
use in evoked response measurements (EP).
(Division Sign-Off)
Division of General, Restorative.
and Neurological Devices
510(k) NumberJ§Ž7ILL5